Status | Study |
Recruiting |
Study Name: Pembrolizumab in Patients With Leptomeningeal Disease Condition: Patients With Leptomeningeal Disease Date: 2017-01-03 Interventions: Drug: Pembrolizumab 200mg every 3 weeks |
Recruiting |
Study Name: Ipilimumab and Nivolumab in Leptomeningeal Metastases From Melanoma Condition: Leptomeningeal Carcinomatosis Melanoma Date: 2016-08-29 Interventions: Drug: Nivolumab Other Name: Op |
No longer available |
Study Name: Expanded Access to ANG1005 for Individual Patients Condition: Anaplastic Astrocytoma Anaplastic Oligodendroglioma Breast Date: 2016-04-27 Interventions: Drug: ANG1005 |
Recruiting |
Study Name: A Prospective, Observational Trial on the Diagnostic and Prognostic of LM Condition: Lung Neoplasms Meningeal Carcinomatosis Date: 2015-11-16 |
Not yet recruiting |
Study Name: Different Dose of Methotrexate for the Treatment of Meningeal Carcinomatosis Condition: Meningeal Carcinomatosis Date: 2015-10-26 Interventions: Drug: methotrexate The quantity of methotrexate is different in the two groups. |
Recruiting |
Study Name: Clinical and Pharmacological Study With 2B3-101 in Patients With Breast Cancer and Leptomeningeal Metastases Condition: Meningeal Carcinomatosis Date: 2013-03-18 Interventions: Drug: 2B3-101 50 mg/m2 2B3-101 intravenous 3-weekly administration |
Terminated |
Study Name: Circulating Tumor Cells and Cytology in Cerebrospinal Fluid of Patients Clinically Suspected for Leptomeningeal Metastases Condition: Meningeal Carcinomatosis Date: 2012-10-22 Interventions: Procedure: lumbar puncture |
Withdrawn |
Study Name: Continuous Intraventricular Methotrexate in Treating Patients With Leptomeningeal Disease Condition: Leptomeningeal Metastases Date: 2011-09-19 Interventions: Other: pharmacological study C |
Recruiting |
Study Name: Intrathecal Trastuzumab Administration in Metastatic Breast Cancer Patients Developing Carcinomatous Meningitis Condition: Metastatic Breast Cancer Carcinomatous Meningitis Date: 2011-05-24 Interventions: Drug: Trastuzumab One injection per week during 8 weeks by lumbar puncture or Ommaya Reservoir. 4 levels |
Terminated |
Study Name: Depocyt® With Sorafenib in Neoplastic Meningitis Condition: Neoplastic Meningitis Date: 2009-08-24 Interventions: Drug: DepoCyt Patients were to |